LatestISO 17025Janoshik verified
99.77%
HPLC purity
✓ Passed full QC panel
- Variant
- Tirzepatide 30 mg
- Lot #
- 800-30
- Labeled
- 30 mg
- Actual
- 31.13 mg
- Tested
- Jan 27, 2026
Metabolic Research
Tirzepatide
CAS 2023788-19-2>99% purity
Tirzepatide analytical reference material for qualified in vitro laboratory research only. Not a consumer product. Not for human or animal use.
Dosage
Quantity
1
$109.00
Bundle & Save
Order within --h --m --s to ship today
Cutoff 1:00 PM CST your time.
Lyophilized Fast shipping Secure checkout
Add-onLaboratory prep material
Bacteriostatic (BAC) Water
Solvent for qualified lab workflows.
$10 · 10 ml
Certificate of Analysis
Third-party testedISO/IEC 17025 accredited
Compound Information
Technical specifications
◇ Molecular profile
What is Tirzepatide?
- Type
- Synthetic peptide
- CAS number
- 2023788-19-2
- Molecular weight
- 4813.45 g/mol
◇ Storage requirements
Stability information
Avoid freeze/thaw cyclesProtect from lightKeep refrigerated
❄
Lyophilized (powder)
−20 °C · 24+ months
◐
Reconstituted
2–8 °C · ~30 days
More in Metabolic Research
All products
Sources & References
Peer-reviewed research
New England Journal of Medicine
Triple hormone-receptor agonism with Tirzepatide in obesity — Phase 2 findings
2023
Jastreboff AM, et al.
View source The Lancet
Tirzepatide evaluated in adults with type 2 diabetes — Phase 2
2023
Rosenstock J, et al.
View source Nature Medicine
Tirzepatide in metabolic dysfunction-associated steatotic liver disease
2024
Sanyal AJ, et al.
View source Lancet Diabetes & Endocrinology
Effects of Tirzepatide on body composition
2025
Coskun T, et al.
View source PubMed Central
Triple agonism approaches in obesity pharmacotherapy
2025
View source PubMed Central
Tirzepatide as a next-generation obesity therapy candidate
2025
View source PubMed Central
Efficacy and safety of Tirzepatide — systematic review
2024
View source ClinicalTrials.gov
Tirzepatide clinical trials registry
View sourceTirzepatide
$109.00
Tirzepatide
20 mg · $109.00 each
$109.00